1Seymour M T, Stenning S P, Cassidy J. Attirudes and practice in the management of metastatic colorectal cancer in Britain.Colorectal caneer working party of the UK medical research council [J]. Clin Oncol,1997,9(4):248-251.
2Hoff P M, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer results of a randomized phase Ⅲ study[J]. J Clin Oncol,2001,19(
3The Meta-analysis Group In Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer [J].J Clin Oncol, 1998,16(1):301-308.
4Schmoll H J. Development of treatment for advanced colorectal cancer: infusional 5-Fu and the role of new agents [J].Eur J Cancer, 1996,32(suppl.5):18-22.
5Borner M M,Dietrich D,Stupp R,et al.Phase Ⅱ study of capecitabine and oxaliplatin in first-and second-line treatment of advanced or metastatic colorectal cancer[J]. J Clin Oncol,2002,20(7):1759 - 1766.
